FIELD: medicine; oncology; endocrinology.
SUBSTANCE: invention can be used to assess the risk of thyroid cancer in a patient with thyroid nodules. A molecular genetic study of cytological samples of the thyroid gland is carried out, based on the results of which the expression level of miR145 and miR7 is determined. The probability of having thyroid cancer P1 is calculated. In the case of P1<0.5, it is concluded that there is a low probability of thyroid cancer. At P1≥0.5 it is concluded that there is a high probability of thyroid cancer.
EFFECT: method improves the efficiency of cancer diagnosis in patients with thyroid nodules by determining the expression level of miR145 and miR7 in a thyroid sample.
1 cl, 1 dwg, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF THYROID NEOPLASMS | 2019 |
|
RU2705110C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF NODULAR FORMATIONS OF THE HUMAN THYROID GLAND | 2021 |
|
RU2757347C1 |
| METHOD FOR COMPLEX PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NODULES OF THE THYROID GLAND | 2022 |
|
RU2805941C1 |
| METHOD FOR ASSESSING THE RISK OF THYROID CANCER IN A PATIENT WITH NODULAR THYROID FORMATIONS | 2019 |
|
RU2725749C1 |
| METHOD FOR PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF BENIGN AND MALIGNANT NODULAR FORMATIONS OF THE THYROID GLAND | 2021 |
|
RU2783304C1 |
| METHOD FOR DETECTING BENIGN AND MALIGNANT NEW GROWTHS OF HUMAN THYROID | 2014 |
|
RU2548773C1 |
| METHOD FOR PREOPERATIVE DIFFERENTIAL DIAGNOSIS OF ANAPLASTIC THYROID CANCER | 2021 |
|
RU2759128C1 |
| METHOD FOR DIAGNOSING MALIGNANT NEOPLASMS OF THYROID GLAND | 2023 |
|
RU2820815C1 |
| METHOD FOR PREOPERATIVE DIAGNOSIS OF MEDULLARY THYROID CANCER | 2023 |
|
RU2819521C1 |
| METHOD OF DETERMINING RISK OF DEVELOPING PAPILLARY THYROID CANCER | 2023 |
|
RU2807880C1 |
